Valve Endocarditis Indications and Timing of Surgery

Size: px
Start display at page:

Download "Valve Endocarditis Indications and Timing of Surgery"

Transcription

1 Valve Endocarditis Indications and Timing of Surgery Michele Di Mauro, MD, PhD Cardiac Surgeon and Cardiologist Heart Department,SS Annunziata H, Chieti, Italy

2 What do the guidelines say?

3 Heart Failure American Heart Association Native valve IE with valve dysfunction causing HF Prosthesis valve IE with dehiscence, fistula, dysfunction cau sing HF EARLY during initial hospitalization and before completion of a full course of antibiotics ESC/EACTS Aortic or mitral NVE or PVE with severe acute regurgitation, obstruction, or fistula causing refractory pulmonary edema or cardiogenic shock EMERGENT (within 24h) Aortic or mitral NVE or PVE with severe acute regurgitation, obstruction, or fistula causing HF or poor hemodynamics URGENT (within few days)

4 Uncontrolled infection Elective surgery? American Heart Association Heart block Annular or aortic abscess, destructive penetrating lesions Relapsing PVE Persistent infection (Persistent bacteremia or fever lasting >5 7 d after the start of appropriate antimicrobial therapy) EARLY ESC/EACTS Elective/Urgent Fungi or multiresistant organisms PVE caused by staphylococci or gram-negative bacteria Urgent Locally uncontrolled infection (abscess, false aneurysm, fist ula, enlarging vegetation) Persisting positive blood cultures despite appropriate antibio tic therapy

5 Prevention of embolism American Heart Association Recurrent emboli and persistent or enlarging vegetations despite appropriate antibiotic therapy Severe valve regurgitation Mobile vegetations >10 mm, particularly when involving the anterior leaflet of the mitral valve EARLY ESC/EACTS Aortic or mitral NVE, or PVE with persistent vegetations >10 mm after embolic episode despite appropriate antibiotic therapy Aortic or mitral NVE with vegetations >10 mm, associated with s evere valve stenosis or regurgitation, and low operative risk Aortic or mitral NVE, or PVE with isolated very large vegetations (>15 mm) URGENT (within few days)

6 55% Concerns from Guidelines Early during initial hospitalization and before completion of a full course of antibiotics 25% Elective (delayed) >1-2 weeks Fungi or multiresistant organisms PVE caused by staphylococci or gram-negative bacteria AHA 35% ESC/EACTS AHA gives a too variable range for timing with the term early ESC suggests to delay surgery after 1 or 2 week of antibiotics BUT in presence of particularly aggressive germs such as fungi and staphylococci and in multiresistant germs where antibiotics are more prone to fail

7 H A V R Take Home Message 1

8 Why should we wait?

9 What does literature say? High Level of evidence Low RCT Meta-analysis Propensity Score Observational studies Kang et al 2012 Liang et al 2016 Lalani et al Many others Left-sided IE Early surgery vs Conventional treatment 16 studies 8141 patients All studies but 1 (early vs delayed) Early surgery vs medical therapy International Collabora tion on Endocarditis Prospective Cohort Study (ICE-PCS) database 619 matched patients

10 Randomized Control Trial

11 Randomized Control Trial Primary end-point A composite of in-hospital death or clinic al embolic events that occurred within 6 weeks after randomization Secondary end-point Death from any cause, embolic events, recurrence of infective endocarditis, and repeat hospitalizatio n due to the development of congestive HF Kang et al. Early Surgery versus Conventional Treatment for Infective Endocarditis. NEJM 2012;366:

12 In hospital mortality long-term mortality Optimal timing for early surgery in infective endocarditis: a meta-analysis Liang et al ICVTS 2016;22: We concluded that early surgery was associat ed with lower in-hospital and long-term mortali ty compared with non-early surgical treatment for IE

13 Propensity Score Study Lalani et al. Analysis of the Impact of Early Surgery on In-hospital Mortality of Native Valve Endocarditis: Use of Propensity Score and Instrumental Variable Methods to Adjust for Treatment Selection Bias. Circulation March 2; 121(8): ICE-PCS Data from Overall The ICE-PCS cohort consisted of 2760 Patients; 1552 NVIE Early vs Medical Therapy 720 Early surgery vs 832 MT Matched cohorts 619 matched patients for each group using PS

14 Cerebral Complications Patients with stroke Better delayed surgery Patients with c. hemorrhage Better delayed surgery STROKE HEMORRHAGE

15 ISCHEMIC STROKE This text can be replaced with your own text EARLY LATE 584 DELAYED 317 EARLY

16 HEMORRHAGIC STROKE This text can be replaced with your own text EARLY LATE 110 DELAYED 31 EARLY

17 MIXED C.E. This text can be replaced with your own text EARLY LATE DELAYED EARLY

18 Moderate Cerebral Complications This text can be replaced with your own text NIHSS 10 Moderate CC

19 Our Experience The Italian Registry of Heart Valve and Prosthesis Infective Endocarditis Surgically Treated The Italian Registry of Valve and Prosthesis Infective Endocarditis Sur gically Treated has been developed since 2013, starting from an idea of Dr. Guglielmo Actis Dato, with the aid of Dr. Michele Di Mauro It was developed on behalf of GIROC (The Italian Group of Research for Outcome in Cardiac Surgery) In 2015, The Italian Society For Cardiac Surgery (SICCH) endorsed GIR OC and this registry

20 Our Experience Vicenza Napoli - II Università-Monaldi 822 Torino - Ospedale Mauriziano 342 Bergamo - Ospedale Papa Giovanni XXIII 305 Genova - Ospedale San Martino-Università 265 Varese - Ospedale Universitario 249 San Donato M.se - IRCCS San Donato M.se 240 Torino - Ospedale Universitario Molinette 228 Milano - IRCCS San Raffaele 224 Bologna - Ospedale Malpighi Sant'Orsola 223 Parma - Ospedale Maggiore 216 Milano- Ospedale Sacco 216 Udine - Ospedale Universitario 165 Verona - Borgo Trento 128 Pisa - Ospedale Universitario 119 Brescia - Spedali Civili 76 Ome (BS) - Fondazione Poliambulanza 71 Lecce - Ospedale V Fazi 66 Roma - Ospedale San Camillo Forlanini 65 Vincenza - Ospedale San Bortolo 32 Catanzaro - Clinica Sant'Anna 21 Bari - Clinica Santa Maria 11 To the last update (February 2018), 21 Italian Centers joined the registry: 4084 patients from 1979 to 2018

21 Low and High Risk! data from the Italian Experience (GIROC) Your Text Here You can simply impress your audience and add a unique zing and appeal to your Presentations. Endoscore 10% High risk Sensitivity 79% Specificity 72% Early mortality Low risk High Risk

22 Let s summarize!

23 Timing Summary small sized stroke Add Text Simple PowerPoint Cerebral hemorrhage Large sized stroke

24 Thank you for your attention! Coming together is a beginning! Keeping together is progress! Working together is SUCCESS. Henry Ford

General management of infective endocarditis

General management of infective endocarditis General management of infective endocarditis Team approach in infective endocarditis Gilbert Habib La Timone Hospital Marseille - France Eurovalves Barcelona 2017 The echolab «Heart Team" Infective Endocarditis

More information

IE with cerebral hemorrhage

IE with cerebral hemorrhage IE with cerebral hemorrhage Gilbert Habib / Patrizio Lancellotti La Timone Hospital Marseille - France Palermo, 26 April 2018 Case report: aortic bioprosthetic IE History of the disease 75 year-old man

More information

Indications chirurgicales dans l endocardite infectieuse

Indications chirurgicales dans l endocardite infectieuse Indications chirurgicales dans l endocardite infectieuse Bruno Hoen ICE AEPEI Agenda Indications of surgery in IE: current guidelines Impact of early valve surgery (EVS) on the prognosis of IE: is the

More information

Surgical Indications of Infective Endocarditis in Children

Surgical Indications of Infective Endocarditis in Children 2016 Annual Spring Scientific Conference of the KSC April 15-16, 2016 Surgical Indications of Infective Endocarditis in Children Cheul Lee, MD Pediatric and Congenital Cardiac Surgery Seoul St. Mary s

More information

Challenging clinical situation

Challenging clinical situation Challenging clinical situation A young patient with prosthetic aortic valve endocarditis Gilbert Habib La Timone Hospital Marseille - France October 25 th 2014 Case report History of the disease Clinical

More information

PRINCIPLES OF ENDOCARDITIS

PRINCIPLES OF ENDOCARDITIS 015 // Endocarditis CONTENTS 140 Principles of Endocarditis 141 Native Valve Endocarditis 143 Complications of Native Valve Endocarditis 145 Right Heart Endocarditis 145 Prosthetic Valve Endocarditis 146

More information

Endocarditis: Medical vs. Surgical Treatment. Nabin K. Shrestha, MD, MPH Infectious Diseases

Endocarditis: Medical vs. Surgical Treatment. Nabin K. Shrestha, MD, MPH Infectious Diseases Endocarditis: Medical vs. Surgical Treatment Nabin K. Shrestha, MD, MPH Infectious Diseases Conflicts of interest Nothing to disclose 2 Complications of infective endocarditis Local complications Heart

More information

Heart on Fire: Infective Endocarditis. Objectives. Disclosure 8/27/2018. Mary McGreal DNP, RN, ANP-c, CCRN

Heart on Fire: Infective Endocarditis. Objectives. Disclosure 8/27/2018. Mary McGreal DNP, RN, ANP-c, CCRN Heart on Fire: Infective Endocarditis Mary McGreal DNP, RN, ANP-c, CCRN Objectives Discuss the incidence of infective endocarditis? Discuss the pathogenesis of infective endocarditis? Discuss clinical

More information

Update on the prevention, diagnosis and management of Infective Endocarditis (IE)

Update on the prevention, diagnosis and management of Infective Endocarditis (IE) Update on the prevention, diagnosis and management of Infective Endocarditis (IE) Dr.Ahmed Yahya Mohammed Alarhabi MD, MsC,FcUSM,FACC,MAHA Consultant Interventional Cardiologist Head of Cardiac Center

More information

PROSTHETIC VALVE ENDOCARDITIS Dr Bernard Prendergast DM FRCP EUROVALVE CONGRESS MADRID NOVEMBER 2013

PROSTHETIC VALVE ENDOCARDITIS Dr Bernard Prendergast DM FRCP EUROVALVE CONGRESS MADRID NOVEMBER 2013 PROSTHETIC VALVE ENDOCARDITIS Dr Bernard Prendergast DM FRCP EUROVALVE CONGRESS MADRID NOVEMBER 2013 Prosthetic Valve Endocarditis A Dangerous Disease Affects 1-6% of prosthetic valves Mechanical and biological

More information

Case-based session. Infective Endocarditis. Applying the new guidelines. A case of large vegetation with neurological complication.

Case-based session. Infective Endocarditis. Applying the new guidelines. A case of large vegetation with neurological complication. Case-based session. Infective Endocarditis. Applying the new guidelines. A case of large vegetation with neurological complication. María Nazarena Pizzi Hospital Universitari Vall d Hebron Barcelona. I

More information

TREATMENT OF ENDOCARDITIS: Destruction and Reconstruction of the Fibrous Skeleton. Gösta B. Pettersson, M.D., Ph.D. No relationships to disclose!

TREATMENT OF ENDOCARDITIS: Destruction and Reconstruction of the Fibrous Skeleton. Gösta B. Pettersson, M.D., Ph.D. No relationships to disclose! TREATMENT OF ENDOCARDITIS: Destruction and Reconstruction of the Fibrous Skeleton Gösta B. Pettersson, M.D., Ph.D. The Cleveland Clinic Foundation No relationships to disclose! Adult Cardiac Surgery Symposium

More information

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators Paris, August 28 th 2011 Is TAVI the definitive treatment in high risk patients? Impact Of Coronary Artery Disease In Elderly Patients Undergoing TAVI: Insight The Italian CoreValve Registry Gian Paolo

More information

Valvular heart disease : Role of medication ( drug and intervention ) Pol.Col.Dr.Kasem Ratanasumawong

Valvular heart disease : Role of medication ( drug and intervention ) Pol.Col.Dr.Kasem Ratanasumawong Valvular heart disease : Role of medication ( drug and intervention ) Pol.Col.Dr.Kasem Ratanasumawong Management of valvular heart disease Accurate diagnosis and disease severity Prevention and treatment

More information

Diagnostic strategy. Dr Pilar Tornos Hospital Vall d Hebron Barcelona

Diagnostic strategy. Dr Pilar Tornos Hospital Vall d Hebron Barcelona Diagnostic strategy Dr Pilar Tornos Hospital Vall d Hebron Barcelona Faculty disclosure Pilar Tornos I disclose the following financial relationships: Paid speaker for Recordati, Edwards. Diagnosis of

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Kang D-H, Kim Y-J, Kim S-H, et al. Early surgery versus conventional

More information

Daniel C. DeSimone, MD Assistant Professor of Medicine

Daniel C. DeSimone, MD Assistant Professor of Medicine Daniel C. DeSimone, MD Assistant Professor of Medicine Faculty photo will be placed here Desimone.Daniel@mayo.edu 2015 MFMER 3543652-1 Infective Endocarditis Mayo School of Continuous Professional Development

More information

Modifiers of the clinical course of infective endocarditis

Modifiers of the clinical course of infective endocarditis Modifiers of the clinical course of infective endocarditis Ulrika Snygg-Martin M.D., Ph.D. Infectious Diseases Clinic Sahlgrenska University Hospital Gothenburg, Sweden Infective endocarditis : modifiers

More information

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands Minimal Invasive Mitral Valve Surgery After Previous Sternotomy Without Aortic Clamping: Short- and Long Term Results of a Single Surgeon Single Institution Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart

More information

Infective Endocarditis عبد المهيمن أحمد

Infective Endocarditis عبد المهيمن أحمد Infective Endocarditis إعداد : عبد المهيمن أحمد أحمد علي Infective endocarditis Inflammation of the heart valve or endocardium of the heart. The agents are usually bacterial, but other organisms can also

More information

Dr Babak Tamizi far MD. Assistant Professor Of Internal Medicine Al-Zahra Hospital Isfahan University Of Medical Sciences

Dr Babak Tamizi far MD. Assistant Professor Of Internal Medicine Al-Zahra Hospital Isfahan University Of Medical Sciences Dr Babak Tamizi far MD. Assistant Professor Of Internal Medicine Al-Zahra Hospital Isfahan University Of Medical Sciences ١ ٢ ٣ A 57-year-old man presents with new-onset fever, shortness of breath, lower

More information

April 16, 09:00-09:15 중앙대학교 윤신원

April 16, 09:00-09:15 중앙대학교 윤신원 April 16, 09:00-09:15 중앙대학교 윤신원 When to perform Echocardiography in IE? Vegetations?(pathologic Whatever the level hallmark) of suspicion Intracardiac abscess? Confirm or R/O at the Earliest opportunity.

More information

Introducing the COAPT Trial

Introducing the COAPT Trial physician INFORMATION Eligible patients Symptomatic functional mitral regurgitation 3+ Not suitable candidates for open mitral valve surgery NYHA functional class II, III, or ambulatory IV Introducing

More information

MULTIVALVULAR INFECTIVE ENDOCARDITIS CLINICAL FEATURES, ECHOCARDIOGRAPHIC DATA AND OUTCOMES

MULTIVALVULAR INFECTIVE ENDOCARDITIS CLINICAL FEATURES, ECHOCARDIOGRAPHIC DATA AND OUTCOMES Article Original MULTIVALVULAR INFECTIVE ENDOCARDITIS CLINICAL FEATURES, ECHOCARDIOGRAPHIC DATA AND OUTCOMES L. ABID, B. JERBI, I. TRABELSI, A. ZNAZEN*, S. KRICHÈNE, D. ABID, M. AKROUT, S. MALLEK, F. TRIKI,

More information

Case Studies in Complex Endocarditis

Case Studies in Complex Endocarditis Case Studies in Complex Endocarditis Vera H. Rigolin, MD Professor of Medicine Northwestern University Feinberg School of Medicine Medical Director, Echocardiography Laboratory Northwestern Memorial Hospital

More information

DICE Session. The endocarditis team. Bernard Iung Bichat Hospital, Paris Diderot University Paris, France

DICE Session. The endocarditis team. Bernard Iung Bichat Hospital, Paris Diderot University Paris, France DICE Session. The endocarditis team Bernard Iung Bichat Hospital, Paris Diderot University Paris, France Faculty disclosure First name - last name I disclose the following financial relationships: Consultant

More information

Valvular Intervention

Valvular Intervention Valvular Intervention Outline Introduction Aortic Stenosis Mitral Regurgitation Conclusion Calcific Aortic Stenosis Deformed Eccentric Calcified Nodular Rigid HOSTILE TARGET difficult to displace prone

More information

Nivolumab nel carcinoma renale metastatico: esperienza italiana

Nivolumab nel carcinoma renale metastatico: esperienza italiana Nivolumab nel carcinoma renale metastatico: esperienza italiana Ugo De Giorgi Istituto Tumori Romagna IRST IRCCS Meldola on behalf of the Italian EAP RCC Group Real world data from the Italian expanded

More information

A Nightmare. R Dulgheru, CHU Liege

A Nightmare. R Dulgheru, CHU Liege A Nightmare R Dulgheru, CHU Liege Faculty disclosure Raluca Dulgheru I have no financial relationships to disclose. MB, 57 years old male 18/03/2016 to the ER for altered mental status, First weight name

More information

VALVULAR HEART DISEASE

VALVULAR HEART DISEASE VALVULAR HEART DISEASE Stenosis: failure of a valve to open completely, obstructing forward flow. - almost always due to a chronic process (e.g., calcification or valve scarring). Insufficiency : failure

More information

What s New in the Guidelines for Surgical Ablation for Atrial Fibrillation?

What s New in the Guidelines for Surgical Ablation for Atrial Fibrillation? What s New in the Guidelines for Surgical Ablation for Atrial Fibrillation? Vinay Badhwar, MD Gordon F. Murray Professor and Chairman Department of Cardiovascular & Thoracic Surgery West Virginia University

More information

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such

More information

Minimally invasive aortic valve surgery: new solutions to old problems.

Minimally invasive aortic valve surgery: new solutions to old problems. SCDU DI CARDIOCHIRURGIA Università degli Studi di Torino Ospedale S. Giovanni Battista Direttore: Prof. Mauro Rinaldi Minimally invasive aortic valve surgery: new solutions to old problems. Prof. Mauro

More information

Acute Valve Regurgitation Catherine M. Otto, MD J. Ward Kennedy-Hamilton Endowed Chair in Cardiology University of Washington, Seattle

Acute Valve Regurgitation Catherine M. Otto, MD J. Ward Kennedy-Hamilton Endowed Chair in Cardiology University of Washington, Seattle Acute Valve Regurgitation Catherine M. Otto, MD J. Ward Kennedy-Hamilton Endowed Chair in Cardiology University of Washington, Seattle No conflicts of interest Acute Aortic Regurgitation Causes aortic

More information

ACUTE CENTRAL PERIFERALEMBOLISM

ACUTE CENTRAL PERIFERALEMBOLISM EAE TEACHING COURSE 2010 Belgrade, Serbia October 22-23, 2010 ACUTE CENTRAL and PERIFERALEMBOLISM Maria João Andrade Lisbon, PT BACKGROUND Stroke is a leading cause of mortality and long-term disability

More information

options in Myeloablative HSCT

options in Myeloablative HSCT Should Busilvex we use AlloSCT in AML options in Myeloablative HSCT Reduced Intensity or Myeloablative preparative protocols? Moderator: Andrea Bacigalupo Reduced Intensity: Arnon Nagler Myeloablative:

More information

Early Surgery versus Conventional Treatment for Infective Endocarditis

Early Surgery versus Conventional Treatment for Infective Endocarditis T h e n e w e ngl a nd j o u r na l o f m e dic i n e original article Early Surgery versus Treatment for Infective Endocarditis Duk-Hyun Kang, M.D., Ph.D., Yong-Jin Kim, M.D., Ph.D., Sung-Han Kim, M.D.,

More information

Mitral valve infective endocarditis (IE) is the most

Mitral valve infective endocarditis (IE) is the most Mitral Valve Replacement for Infective Endocarditis With Annular Abscess: Annular Reconstruction Gregory J. Bittle, MD, Murtaza Y. Dawood, MD, and James S. Gammie, MD Mitral valve infective endocarditis

More information

Endocardite infectieuse

Endocardite infectieuse Endocardite infectieuse 1. Raccourcir le traitement: jusqu où? 2. Proposer un traitement ambulatoire: à partir de quand? Endocardite infectieuse A B 90 P = 0.014 20 P = 0.0005 % infective endocarditis

More information

Evaluating Clinical Risk and Guiding management with SPECT Imaging

Evaluating Clinical Risk and Guiding management with SPECT Imaging Evaluating Clinical Risk and Guiding management with SPECT Imaging Raffaele Giubbini Chair and Nuclear Medicine Unit University & Spedali Civili Brescia- Italy U.S. Congressional Budget Office. Technological

More information

Mitral Valve Disease, When to Intervene

Mitral Valve Disease, When to Intervene Mitral Valve Disease, When to Intervene Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Current ACC/AHA guideline Stages

More information

Infective Endocarditis

Infective Endocarditis Frank Lowy Infective Endocarditis 1. Introduction Infective endocarditis (IE) is an infection of the heart valves. A large number of different bacteria are capable of causing this disease. Depending on

More information

For more information

For more information For more information www.escardio.org/guidelines ESC Guidelines on the Prevention, Diagnosis and Treatment of Infective Endocarditis (New Version 2009)* The Task Force on the Prevention, Diagnosis and

More information

The changing landscape of infective endocarditis (IE)in congenital heart disease (CHD)

The changing landscape of infective endocarditis (IE)in congenital heart disease (CHD) The changing landscape of infective endocarditis (IE)in congenital heart disease (CHD) Rekwan Sittiwangkul,MD Department of Pediatrics. Chiang Mai University Hospital, 24 th March 2018 Infective endocarditis

More information

Disclosures. Native Valve Endocarditis and its Complications. Outline. Outline. Basics. Basics 3/23/2017

Disclosures. Native Valve Endocarditis and its Complications. Outline. Outline. Basics. Basics 3/23/2017 Native Valve Endocarditis and its Complications SCVP and Binford Dammin Society of Infectious Disease Pathologists Shared Companion Meeting USCAP 2017 Annual Meeting Disclosures Relevant financial relationships

More information

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve

More information

Pr AMEL OMEZZINE LETAIEF CHU FarhatHached Sousse

Pr AMEL OMEZZINE LETAIEF CHU FarhatHached Sousse Pr AMEL OMEZZINE LETAIEF CHU FarhatHached Sousse cours de collège infectiologie Sousse le27/02/2013 ENDOCARDITIS There is a change in epidemiology Clinical features of IE remains classical Diagnosis of

More information

Case Report Subacute Staphylococcusepidermidis Bacterial Endocarditis Complicated by Mitral-Aortic Intervalvular Fibrosa Pseudoaneurysm

Case Report Subacute Staphylococcusepidermidis Bacterial Endocarditis Complicated by Mitral-Aortic Intervalvular Fibrosa Pseudoaneurysm Case Reports in Cardiology Volume 2012, Article ID 467210, 4 pages doi:10.1155/2012/467210 Case Report Subacute Staphylococcusepidermidis Bacterial Endocarditis Complicated by Mitral-Aortic Intervalvular

More information

Cardiology III 1/22/2019. Disclosures - none. But first. Objectives. Ischemia EKG s. And second

Cardiology III 1/22/2019. Disclosures - none. But first. Objectives. Ischemia EKG s. And second Disclosures - none Cardiology III Matthew K Hysell, MD Spectrum Health Lakeland St Joseph, MI 1 2 Objectives Review specific high-yield EKG patterns Ischemia Ischemia mimics Electrolytes Review Cardiac/CV

More information

Dysfunction of transcatheter mitral valve prosthesis. Early valve degeneration or thrombosis - that is the question.

Dysfunction of transcatheter mitral valve prosthesis. Early valve degeneration or thrombosis - that is the question. Dysfunction of transcatheter mitral valve prosthesis. Early valve degeneration or thrombosis - that is the question. Böhm A., Hricak V., Tomasovic B., Bena M., Postulka J. The National Institute of, Department

More information

In Process, Unpublished STS/ACC TVT Registry Manuscripts

In Process, Unpublished STS/ACC TVT Registry Manuscripts In Process, Unpublished STS/ACC TVT Registry Manuscripts The following pages list current research and publications proposals that have been recently approved, are under analysis, are under manuscript

More information

SCIENTIFIC PROGRAM.

SCIENTIFIC PROGRAM. SCIENTIFIC PROGRAM tipsandtricks2018@thetriumph.com WELCOME LETTER Dear Colleagues, It is a great pleasure to announce the fifth edition of the International meeting Tips and Tricks in Congenital and Structural

More information

Michael Stander, Pharm.D.

Michael Stander, Pharm.D. Michael Stander, Pharm.D. Endocarditis: Goals Epidemiology Presentation of acute and subacute. Diagnosis: What is Dukes Criteria and how do we approach the diagnosis of endocarditis? Treatment: Understand

More information

Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi

Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi SC Cardiochirurgia U Universita degli Studi di Torino PORT-ACCESS TECNIQUE Reduce surgical trauma Minimize disruption of the chest wall

More information

Percutaneous Mitral Valve Repair

Percutaneous Mitral Valve Repair Percutaneous Mitral Valve Repair MitraClip: Procedure, Data, Patient Selection Chad Rammohan, MD FACC Director, Cardiac Cath Lab El Camino Hospital Mountain View, California Mitral Regurgitation MitraClip

More information

Echocardiography after stroke - where to look

Echocardiography after stroke - where to look Echocardiography after stroke - where to look Vuyisile T. Nkomo, MD,MPH, FACC, FASE Joint Cardiac Imaging Society of South Africa/Mayo Clinic Echocardiography Workshop 2017 2016 MFMER slide-1 Disclosures

More information

Education and Training

Education and Training Curriculum Vitae of Dr Bernardo Cortese, MD, FESC Page 1 of 5 Statement of Education and Qualifications Name (First, Middle, Last) Academic Qualification(s) Bernardo Cortese, 27.11.1975 MD Cardiologist

More information

NON INVASIVE VENTILATION

NON INVASIVE VENTILATION NON INVASIVE VENTILATION and BEYOND B ologna Italy 7 8 JUNE 2013 Aula Magna Nuove Patologie Pav. 5 Policlinico S. Orsola - Malpighi final program friday 7 JUNE 2013 13.00 Registration 13.15 Welcome address

More information

Right-Sided Bacterial Endocarditis

Right-Sided Bacterial Endocarditis New Concepts in the Treatment of the Uncontrollable Infection Agustin Arbulu, M.D., Ali Kafi, M.D., Norman W. Thorns, M.D., and Robert F. Wilson, M.D. ABSTRACT Our experience with 25 patients with right-sided

More information

Infective Endocarditis

Infective Endocarditis Infective Endocarditis Infective Endocarditis Historical Perspective.. A concretion larger than a pigeon s egg; contained in the left auricle. Burns, 1809 Osler s Gulstonian lectures provided the 1 st

More information

SONOGRAPHER & NURSE LED VALVE CLINICS

SONOGRAPHER & NURSE LED VALVE CLINICS SONOGRAPHER & NURSE LED VALVE CLINICS Frequency of visits and alerts AORTIC STENOSIS V max > 4.0 m/s or EOA < 1.0 cm 2 V max 3.5 4.0 m/s + Ca+ V max 3.0 4.0 m/s or EOA 1.0-1.5 cm 2 V max 2.5 3.0 m/s every

More information

New murmur: acute valvular regurgitations. A.Pasquet, MD,PhD. UCL -Cliniques Saint Luc

New murmur: acute valvular regurgitations. A.Pasquet, MD,PhD. UCL -Cliniques Saint Luc New murmur: acute valvular regurgitations. A.Pasquet, MD,PhD UCL -Cliniques Saint Luc Acute valvular regurgitation Clinical case Mr Dupont, a 53 y old men, without any particular medical history On Thursday

More information

You Won t Believe What I Saw on. Disclosures. Goals. Dimensions 2013 October 18 th Michael Pfeiffer, MD. No Financial Disclosures

You Won t Believe What I Saw on. Disclosures. Goals. Dimensions 2013 October 18 th Michael Pfeiffer, MD. No Financial Disclosures You Won t Believe What I Saw on that ECHO! Dimensions 2013 October 18 th Michael Pfeiffer, MD Disclosures No Financial Disclosures Goals Review unusual and unique echocardiographic images. Briefly present

More information

True cryptogenic stroke

True cryptogenic stroke True cryptogenic stroke Arne Lindgren, MD, PhD Dept of Clinical Sciences Lund, Neurology, Lund University Dept of Neurology and Rehabilitation Medicine Skåne University Hospital Lund, Sweden Disclosures

More information

In Process, Unpublished STS/ACC TVT Registry Manuscripts

In Process, Unpublished STS/ACC TVT Registry Manuscripts In Process, Unpublished STS/ACC TVT Registry Manuscripts The following pages list current research and publications proposals that have been recently approved, are under analysis, are under manuscript

More information

DECISION MAKING DEL CARDIOCHIRURGO NELL INSUFFICIENZA MITRALICA: ISTRUZIONI D USO D CARDIOLOGO

DECISION MAKING DEL CARDIOCHIRURGO NELL INSUFFICIENZA MITRALICA: ISTRUZIONI D USO D CARDIOLOGO DECISION MAKING DEL CARDIOCHIRURGO NELL INSUFFICIENZA MITRALICA: ISTRUZIONI D USO D PER IL CARDIOLOGO GUIDELINES IN ASYMPTOMATIC MR ACC/AHA ESC Antonio Miceli Heart Hospital Monasterio Foundation NATURAL/

More information

Case Reviews: Hemodynamic Calculations in Valvular Regurgitation

Case Reviews: Hemodynamic Calculations in Valvular Regurgitation Case Reviews: Hemodynamic Calculations in Valvular Regurgitation Case 5 History: 69-year-old man with orthotopic heart transplant 15 years ago. Inferior MI several years ago. Recurrent CHF. Currently dyspneic

More information

TNT Session. The latest clinical evidence in diabetics for the Amphilimus TM eluting polymer-free DES. Rafael Romaguera, MD

TNT Session. The latest clinical evidence in diabetics for the Amphilimus TM eluting polymer-free DES. Rafael Romaguera, MD TNT Session The latest clinical evidence in diabetics for the Amphilimus TM eluting polymer-free DES Rafael Romaguera, MD Hospital de Bellvitge Barcelona Spain Disclosure Statement of Financial Interest

More information

ICE: Echo Core Lab-CRF

ICE: Echo Core Lab-CRF APPENDIX 1 ICE: Echo Core Lab-CRF Study #: - Pt Initials: 1. Date of study: / / D D M M M Y Y Y Y 2. Type of Study: TTE TEE 3. Quality of Study: Poor Moderate Excellent Ejection Fraction 4. Ejection Fraction

More information

Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical. The Houston Aortic Symposium February 23-25, 2017

Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical. The Houston Aortic Symposium February 23-25, 2017 James S. Gammie, MD Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical The Houston Aortic Symposium February 2-25, 2017 Disclosure Statement of Financial Interest Within

More information

NATIONAL HEART FOUNDATION HOSPITAL & RESEARCH INSTITUTE

NATIONAL HEART FOUNDATION HOSPITAL & RESEARCH INSTITUTE Welcome INFECTIVE ENDOCARDITIS: WHERE WE ARE AT 2005? DR MD HABIBUR RAHMAN FCPS(Medicine) NATIONAL HEART FOUNDATION HOSPITAL & RESEARCH INSTITUTE DEFINITION OF INFECTIVE ENDOCARDITIS Infective endocarditis

More information

A Diagnostic Dilemma saved by sound

A Diagnostic Dilemma saved by sound A Diagnostic Dilemma saved by sound Dr Syam Ravindranath MBBS DNB, Dr Ash Mukherjee FCEM FACEM We p r e s e n t a d i a g n o s t i c a l l y c h a l l e n g i n g s c e n a r i o in a 59 y e a r old f

More information

ASE 2011 Appropriate Use Criteria for Echocardiography

ASE 2011 Appropriate Use Criteria for Echocardiography ASE 2011 Appropriate Use Criteria for Echocardiography Table 1. TTE for General Evaluation of Cardiac Structure and Function 1 2 Suspected Cardiac Etiology General With TTE Symptoms or conditions potentially

More information

Edwards Transcatheter AVR: Have the Outcomes Changed after CE Approval?

Edwards Transcatheter AVR: Have the Outcomes Changed after CE Approval? Edwards Transcatheter AVR: Have the Outcomes Changed after CE Approval? Update from PARTNER EU and SOURCE Registries T. Lefèvre Disclosure Statement Cardiologist Interventional cardiologist 1 st PABV in

More information

Apport de la TEP au FDG dans les infections cardiovasculaires François Rouzet, MD, PhD

Apport de la TEP au FDG dans les infections cardiovasculaires François Rouzet, MD, PhD Apport de la TEP au FDG dans les infections cardiovasculaires François Rouzet, MD, PhD Service de Médecine Nucléaire, GH Bichat-Claude Bernard, Paris, France LVTS (Inserm U1148), Team 4: cardiovascular

More information

Treatment of Infective Endocarditis:

Treatment of Infective Endocarditis: Treatment of Infective Endocarditis: A 1-Year Comparative Analysis JAMES V. RICHARDSON, M.D., ROBERT B. KARP, M.D., JOHN W. KIRKLIN, M.D., AND WILLIAM E. DISMUKES, M.D. SUMMARY The results of surgical

More information

A pregnant patient with a prosthetic valve Giacomo Boccuzzi, MD, FESC

A pregnant patient with a prosthetic valve Giacomo Boccuzzi, MD, FESC A pregnant patient with a prosthetic valve Giacomo Boccuzzi, MD, FESC Department of Invasive Cardiology, Ospedale San Giovanni Bosco, Turin, Italy *C.V. was born the 24th May 1980 Rheumatic fever during

More information

Update interventional Cardiology Hans Rickli St.Gallen

Update interventional Cardiology Hans Rickli St.Gallen Update interventional Cardiology 2012 Hans Rickli St.Gallen 26.11.2012 Review of Literature ESC-Highlights TCT/AHA-Highlights Update interventional cardiology 2012 Structural Heart Disease Transcatheter

More information

Preliminary Scientific Program

Preliminary Scientific Program Preliminary Scientific Program 28-29 MARCH 2019 rome, auditorium del massimo The Società Italiana di Urologia, is happy to present the third edition of a global event dedicated to Live Surgery in Urology:

More information

Standarized definition of bioprosthetic valve deterioration and failure

Standarized definition of bioprosthetic valve deterioration and failure Translational aortic valve research. From biology to treatment Standarized definition of bioprosthetic valve deterioration and failure Anna Sonia Petronio, MD, FESC Head of Cardiac Catheterization Lab

More information

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Innovative Procedures, Devices & State of the Art Care for Arrhythmias, Heart Failure & Structural Heart Disease October 8-10,

More information

Apport des recommandations européennes

Apport des recommandations européennes Apport des recommandations européennes Gilbert Habib Cardiology Department- La Timone Marseille - France Bordeaux le 28 Juin 2011 Infective Endocarditis: a changing disease new high-risk subgroups IVDA

More information

Diagnosis and management of bacterial endocarditis in 2003 Blaithnead Murtagh, MD, O.H. Frazier, MD, and George V. Letsou, MD

Diagnosis and management of bacterial endocarditis in 2003 Blaithnead Murtagh, MD, O.H. Frazier, MD, and George V. Letsou, MD Diagnosis and management of bacterial endocarditis in 2003 Blaithnead Murtagh, MD, O.H. Frazier, MD, and George V. Letsou, MD The diagnosis of infective endocarditis has been notoriously difficult. Over

More information

BASIC KNOWLEDGE ABOUT INFECTIVE ENDOCARDITIS FOR CLINICIAN

BASIC KNOWLEDGE ABOUT INFECTIVE ENDOCARDITIS FOR CLINICIAN BASIC KNOWLEDGE ABOUT INFECTIVE ENDOCARDITIS FOR CLINICIAN When should I suspect infective endocarditis? Antibiotic regimen Patient care after completion of treatment Prophylactic Regimens Prosthetic Valve

More information

Clinical Practice Guidelines and the Under Treatment of Concomitant AF Vinay Badhwar, MD

Clinical Practice Guidelines and the Under Treatment of Concomitant AF Vinay Badhwar, MD Clinical Practice Guidelines and the Under Treatment of Concomitant AF Vinay Badhwar, MD Gordon F. Murray Professor and Chairman Department of Cardiovascular & Thoracic Surgery WVU Heart and Vascular Institute

More information

Echocardiography in Endocarditis

Echocardiography in Endocarditis Echocardiography in Endocarditis Bicol Hospital, Legazpi City, Philippines July 2016 Gregg S. Pressman MD, FACC, FASE Einstein Medical Center Philadelphia, USA Demographics of IE Incidence is 1.4 12.7/100,000

More information

Microbiological diagnosis of infective endocarditis; what is new?

Microbiological diagnosis of infective endocarditis; what is new? Microbiological diagnosis of infective endocarditis; what is new? Dr Amani El Kholy, MD Professor of Clinical Pathology (Microbiology), Faculty of Medicine, Cairo University ESC 2017 1 Objectives Lab Diagnostic

More information

Cardiothoracic and Cardiothoracic Surgery ICD-10-CM 2014: Reference Mapping Card

Cardiothoracic and Cardiothoracic Surgery ICD-10-CM 2014: Reference Mapping Card 2014: Reference Mapping Card 162.3 Malignant neoplasm upper lobe lung 162.5 Malignant neoplasm lower lobe lung 162.9 lung/bronchus 396.2 396.3 Mitral insufficiency, aortic stenosis Mitral aortic valve

More information

TAVI Implantation: Rapid Pacing, Pre and Post Dilatation

TAVI Implantation: Rapid Pacing, Pre and Post Dilatation TAVI Summit 2012 Seoul, September 9, 2012 TAVI Implantation: Rapid Pacing, Pre and Post Dilatation Eberhard Grube, MD, FACC, FSCAI Medizinische i i Klinik ik und Polikinik II, University i Hospital Bonn,

More information

Endocarditis of the Aortic Valve

Endocarditis of the Aortic Valve 19 th - 20 th may 2017 Under the auspice of Workshop Endocarditis of the Aortic Valve FINAL PROGRAMME Forum Guido Monzani Centro di Formazione e Cultura Via Aristotele, 33 Modena Italy WORKSHOP Cristina

More information

results in stenosis or insufficiency (regurgitation or incompetence), or both.

results in stenosis or insufficiency (regurgitation or incompetence), or both. results in stenosis or insufficiency (regurgitation or incompetence), or both. The outcome of valvular disease depends on : 1-the valve involved 2-the degree of impairment 3-the cause of its development

More information

Case Report Subacute Staphylococcusepidermidis Bacterial Endocarditis Complicated by Mitral-Aortic Intervalvular Fibrosa Pseudoaneurysm

Case Report Subacute Staphylococcusepidermidis Bacterial Endocarditis Complicated by Mitral-Aortic Intervalvular Fibrosa Pseudoaneurysm Hindawi Publishing Corporation Case Reports in Cardiology Volume 2012, Article ID 467210, 4 pages doi:10.1155/2012/467210 Case Report Subacute Staphylococcusepidermidis Bacterial Endocarditis Complicated

More information

41 st COURSE ON ADVANCES IN NEPHROLOGY, DIALYSIS, AND TRANSPLANTATION Milan, December 5-8, 2009

41 st COURSE ON ADVANCES IN NEPHROLOGY, DIALYSIS, AND TRANSPLANTATION Milan, December 5-8, 2009 In collaboration with Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena 41 st COURSE ON ADVANCES IN NEPHROLOGY, DIALYSIS, AND TRANSPLANTATION Milan, December 5-8, 2009 Directors

More information

7. Echocardiography Appropriate Use Criteria (by Indication)

7. Echocardiography Appropriate Use Criteria (by Indication) Criteria for Echocardiography 1133 7. Echocardiography Criteria (by ) Table 1. TTE for General Evaluation of Cardiac Structure and Function Suspected Cardiac Etiology General With TTE 1. Symptoms or conditions

More information

Where are italian anesthesiologists and intensive care specialists publishing? A quantitative analysis of publication activity

Where are italian anesthesiologists and intensive care specialists publishing? A quantitative analysis of publication activity proceedings in Intensive Care Cardiovascular Anesthesia ORIGINAL ARTICLE 48 Where are italian anesthesiologists and intensive care specialists publishing? A quantitative analysis of publication activity

More information

TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con

TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con Dimitrios C. Angouras, MD, FETCS Associate Professor of Cardiac Surgery National and Kapodistrian University of Athens,

More information

Valve Replacement in Patients With Endocarditis and Acute Neurologic Deficit

Valve Replacement in Patients With Endocarditis and Acute Neurologic Deficit Valve Replacement in Patients With Endocarditis and Acute Neurologic Deficit A. Marc Gillinov, MD, Rinoo V. Shah, MD, William E. Curtis, MD, R. Scott Stuart, MD, Duke E. Cameron, MD, William A. Baumgartner,

More information

Functional Mitral Regurgitation; therapeutic continuum overview. Michele Senni. Cardiologia 1 Scompenso e Trapianti di Cuore A.O. PAPA GIOVANNI XXIII

Functional Mitral Regurgitation; therapeutic continuum overview. Michele Senni. Cardiologia 1 Scompenso e Trapianti di Cuore A.O. PAPA GIOVANNI XXIII Functional Mitral Regurgitation; therapeutic continuum overview Michele Senni Cardiologia 1 Scompenso e Trapianti di Cuore A.O. PAPA GIOVANNI XXIII Functional Mitral Regurgitation FMR is not the result

More information

Heart Valves: Before and after surgery

Heart Valves: Before and after surgery Heart Valves: Before and after surgery Tim Sutton, Consultant Cardiologist Middlemore Hospital, Auckland Auckland Heart Group Indications for intervention in Valvular disease To prevent sudden death and

More information